已发表论文

开发和验证用于胃癌患者预后的 RNA 甲基化调节剂组合

 

Authors Zhang J, Piao H, Wang Y, Meng X, Yang D, Zhao Y, Zheng Z

Received 12 August 2020

Accepted for publication 16 September 2020

Published 23 October 2020 Volume 2020:13 Pages 10785—10795

DOI https://doi.org/10.2147/OTT.S276239

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr William Cho

Background: Gastric cancer (GC) accounts for high mortality. RNA methylation has recently gained interest as markers in specific tumors. This study aimed to uncover the function of the roles of 25 RNA methylation regulators in GC.
Methods: RNA sequence and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. “STRING” and R were performed to analyze the correlation among the methylase. COX and LASSO were performed to screen for prognostic associated RNA methylation regulators. A prognostic model was established based on the expression of methylase. RT-PCR and immunohistochemistry detected the expression of methylase in GC cells and tissue. Kaplan–Meier curve and Cox analysis were applied to evaluate the effectiveness of the model.
Results: The prediction model was established based on the expression of m6A RNA methylation regulators FTO (fat mass and obesity-associated) and RBM15 (RNA binding motif protein 15). Based on the model, GC patients were divided into “high risk” and “low risk” groups to compare the differences in survival. The model was re-evaluated with the clinical data of our center.
Conclusion: The two-methylase combination model was an independent prognostic factor of GC.
Keywords: gastric cancer, prognosis, least absolute shrinkage and selection operator, survival analysis, RNA methylation